Research of bone formation signaling in osteoblast
Research of bone formation signaling in osteoblast
批准号:
17590961
负责人:
KAJI Hiroshi
金额:
$1.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1 We examined the effects of parathyroid hormone (PTH), the putative potent bone forming reagent, on Smad3 and beta-catenin in osteoblastic cells. PTH and Smad3 induced the expression of beta-catenin. These actions of PTH were through both cAMP and calcium/protein kinase C systems. Moreover, PTH enhanced the transcriptional activity induced by beta-catenin. This PTH-Smad3-beta-catenin signal seemed to be associated with anti-apoptotic effects of PTH in osteoblasts. 2 We have clarified the significance of Smad3 in bone formation. Smad3 suppressed the differentiation into osteoblasts induced by bone morphogenetic protein-2 in mouse mesenchymal ST-2 cells. On the other hand, in mouse osteoblastic MC3T3-E1 cells, the induction of Smad3 on ALP activity and type I collagen expression decreased during differentiation, but the effects of Smad3 on the expressions of Runx2 and osteocalcin converted to induction from suppression during differentiation. Smad3 modulated the expression of other mineralization-related factors. 3 DNA microarray analysis with 45000 genes were performed between control and Smad3-overexpressed MC3T3-E1 cells treated with Erk1/2 inhibitor. The significance of several putative bone formation-related genes including known and unknown genes is being analyzed at the present. The expression vectors of unknown genes were made and their functions are investigated in osteoblasts. 4 MC3T3-E1 cells, which overexpressed Smad7, an inhibitory Smad, were developed. Smad7 suppressed proliferation, differentiation, the production of bone matrix proteins and mineralization in osteoblasts. Moreover, PTH induced the expression of Smad7, suggesting that Smad7 may be the target of the inhibition of bone formation.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Parathyroid hormone increases beta-catenin levels through Smad3 in mouse osteoblastic cells.
甲状旁腺激素通过 Smad3 增加小鼠成骨细胞中的 β-连环蛋白水平。
DOI:
--
发表时间:
2006
期刊:
Endocrinology 147(5)
影响因子:
--
作者:
[Nambu T, Arai H, Komatsu Y, Yasoda A, Moriyama K, Kanamoto N, Itoh H, Nakao K, 飛松崇子]
通讯作者:
飛松崇子
Expression and functional analysis of menin in a multiple endocrine neoplasia type I (MENI) patient with somatic loss of heterozygosity in chrmosome 11g13 and unidentified germlin mutation of the MENI gene.
一名多发性内分泌肿瘤 I 型 (MENI) 患者中 menin 的表达和功能分析,该患者具有染色体 11g13 杂合性体细胞丢失和 MENI 基因未鉴定的种蛋白突变。
DOI:
--
发表时间:
2006
期刊:
Endocrine 29
影响因子:
--
作者:
[Ozasa A, Komatsu Y, Yasoda A, Miura M, Nakatsuru Y, Sakuma Y, Arai H, Itoh N, Nakao N, 内藤純子]
通讯作者:
内藤純子
Parathyroid hormone increases beta-catenin levels through Smad2 in mouse osteoblastic cells.
甲状旁腺激素通过 Smad2 增加小鼠成骨细胞中的 β-连环蛋白水平。
DOI:
--
发表时间:
期刊:
Endocrinology (In press)
影响因子:
--
作者:
[Makita N, Fujita T, Iiri T, 内藤純子, 飛松崇子]
通讯作者:
飛松崇子
Serum soluble factors induce the proliferation, alkaline phosphatase activity and transforming growth factor-b signal in osteoblastic cells in the patient with hepatitiss C-associated osteosclerosis.
血清可溶性因子诱导丙型肝炎相关骨硬化患者的成骨细胞增殖、碱性磷酸酶活性和转化生长因子-b 信号。
DOI:
--
发表时间:
2006
期刊:
Experimental and Clinical Endocrinolgy & Diabetes 114 (100)
影响因子:
--
作者:
[Makita N, Iiri T et al., Hiroshi Kaji]
通讯作者:
Hiroshi Kaji
Serum soluble factors induce the proliferation, alkaline phosphatase activity and transforming growth factor-b signa in osteoblastic cells in the patient with hepatitiss C-associated osteosclerosis.
血清可溶性因子诱导丙型肝炎相关骨硬化患者的成骨细胞增殖、碱性磷酸酶活性和转化生长因子-b 信号。
DOI:
--
发表时间:
2006
期刊:
Experimental and Clinical Endocrinolgy & Diabetes 114(10)
影响因子:
--
作者:
[Majima T, Komatsu Y, Doi K, Shigemoto M, Takagi C, Fukao A, Kojima M, Tamaki H, Ito J, Nakao K, 梶 博史, Iwashima Y, Takahashi Y, 梶 博史]
通讯作者:
梶 博史
共 6 条
Muscle and bone network system induced by mechanical factors
-
批准号:15K08220
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2015
-
负责人:KAJI Hiroshi
-
依托单位:
Roles of tissue-fibrinolytic system in bone/cartilage regeneration
-
批准号:24590289
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:KAJI Hiroshi
-
依托单位:
Measurement of the neutrino oscillation parameter,θ13, by the Super-Kamiokande detector
-
批准号:22740145
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$1.0万
-
财政年份:2010
-
负责人:KAJI Hiroshi
-
依托单位:
The study of the interactions between muscle and bone/mineral metabolism.
-
批准号:21591179
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:KAJI Hiroshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
AAV介导sTGF-betaRII抑制TGF-beta/Smad2/3信号通路的抗口腔黏膜下纤维化基因治疗研究
-
批准号:JCZRLH202600804
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
-
批准号:82303919
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈鹭跃
-
依托单位:
靶向TGF-beta Ⅱ型受体的核酸适配子对TGF-beta介导PCO形成的抑制作用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:朱小敏
-
依托单位:
癌基因FBN2通过TGF-beta通路促进胃癌肝转移的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:舒洋
-
依托单位:
转录因子FOXA1对TGF-beta介导的肺癌细胞上皮-间充质转化调控作用的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:王学聪
-
依托单位:
端粒缩短触发NLRP3/TGF-beta/Smad3信号通路对IgA肾病重症进展的调控研究
-
批准号:82100738
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:任萍萍
-
依托单位:
BRD2 通过相变调控 TGF-beta 信号通路的分子机制和功能研究
-
批准号:LZ22C070001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:顾舒晨
-
依托单位:
非经典TGF-beta信号通路调控小肠干细胞稳态的作用及机制研究
-
批准号:32000538
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘连胜
-
依托单位:
TGF-beta信号通路促进人类T细胞白血病1型病毒侵染的作用及其机制研究
-
批准号:LY21C010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:赵铁军
-
依托单位:
TGF-beta信号通调控淋巴管形成在单纯疱疹病毒性角膜炎治疗中的作用
-
批准号:82060175
-
项目类别:地区科学基金项目
-
资助金额:34.0万元
-
批准年份:2020
-
负责人:张慧
-
依托单位: